Literature DB >> 8558161

Executive dysfunction in early Alzheimer's disease.

G Binetti1, E Magni, A Padovani, S F Cappa, A Bianchetti, M Trabucchi.   

Abstract

Twenty five patients with probable mild Alzheimer's disease were assessed for deficits in executive functioning and the impact of these deficits on performance in other neuropsychological domains. The Wisconsin card sorting test, the release from proactive interference paradigm, the verbal fluency test, and the Stroop test were adopted to classify patients with (AD+) and without (AD-) executive deficits. Seven of the patients showed an impairment in executive function (AD+), defined as a performance below the cut off score in at least two of these tests. There were no significant differences in clinical assessments, demographic features, or other cognitive functions between patients. Executive dysfunction may be an early additional feature in a subgroup of patients with mild Alzheimer's disease. Impairment on frontal lobe tests does not seem to be related to the severity or duration of disease, or to a different pattern of impairment in other cognitive domains.

Entities:  

Mesh:

Year:  1996        PMID: 8558161      PMCID: PMC486198          DOI: 10.1136/jnnp.60.1.91

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  10 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Short-term retention of individual verbal items.

Authors:  L R PETERSON; M J PETERSON
Journal:  J Exp Psychol       Date:  1959-09

Review 3.  Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

4.  A new clinical scale for the staging of dementia.

Authors:  C P Hughes; L Berg; W L Danziger; L A Coben; R L Martin
Journal:  Br J Psychiatry       Date:  1982-06       Impact factor: 9.319

5.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

6.  Alzheimer's disease: focal cortical changes shown by positron emission tomography.

Authors:  N L Foster; T N Chase; P Fedio; N J Patronas; R A Brooks; G Di Chiro
Journal:  Neurology       Date:  1983-08       Impact factor: 9.910

7.  Heterogeneity in dementia of the Alzheimer type: evidence of subgroups.

Authors:  R Mayeux; Y Stern; S Spanton
Journal:  Neurology       Date:  1985-04       Impact factor: 9.910

8.  Semantic encoding deficits in frontal lobe disease and amnesia.

Authors:  M Freedman; L S Cermak
Journal:  Brain Cogn       Date:  1986-01       Impact factor: 2.310

9.  Neuropsychological heterogeneity in mild Alzheimer's disease.

Authors:  G Binetti; E Magni; A Padovani; S F Cappa; A Bianchetti; M Trabucchi
Journal:  Dementia       Date:  1993 Nov-Dec

10.  Frontal dysfunction and memory deficits in the alcoholic Korsakoff syndrome and Alzheimer-type dementia.

Authors:  M D Kopelman
Journal:  Brain       Date:  1991-02       Impact factor: 13.501

  10 in total
  46 in total

Review 1.  Executive control functions in degenerative dementias: a comparative review.

Authors:  L M Duke; A W Kaszniak
Journal:  Neuropsychol Rev       Date:  2000-06       Impact factor: 7.444

2.  Executive dysfunction in Alzheimer disease.

Authors:  Margaret M Swanberg; Rochelle E Tractenberg; Richard Mohs; Leon J Thal; Jeffrey L Cummings
Journal:  Arch Neurol       Date:  2004-04

Review 3.  Metamemory experiments in neurological populations: a review.

Authors:  Jasmeet K Pannu; Alfred W Kaszniak
Journal:  Neuropsychol Rev       Date:  2005-09       Impact factor: 7.444

4.  Categorization of object descriptions in Alzheimer's disease and frontotemporal dementia: limitation in rule-based processing.

Authors:  Murray Grossman; Edward E Smith; Phyllis L Koenig; Guila Glosser; Jina Rhee; Kari Dennis
Journal:  Cogn Affect Behav Neurosci       Date:  2003-06       Impact factor: 3.282

5.  Dysexecutive versus amnestic Alzheimer disease subgroups: analysis of demographic, genetic, and vascular factors.

Authors:  Jesse Mez; Stephanie Cosentino; Adam M Brickman; Edward D Huey; Jennifer J Manly; Richard Mayeux
Journal:  Alzheimer Dis Assoc Disord       Date:  2013 Jul-Sep       Impact factor: 2.703

6.  Mild Alzheimer's disease: a "position paper".

Authors:  J Delrieu; T Voisin; S Andrieu; S Belliard; J Belmin; F Blanchard; M Ceccaldi; J F Dartigues; B Defontaines; S Lehericy; C Mekies; O Moreaud; L Naccache; F Nourhashemi; P J Ousset; F Pasquier; P Payoux; F Puisieux; P Robert; J Touchon; B Vellas; B Dubois
Journal:  J Nutr Health Aging       Date:  2009-06       Impact factor: 4.075

7.  Selectivity of executive function deficits in mild cognitive impairment.

Authors:  Jason Brandt; Eleni Aretouli; Eleanor Neijstrom; Jaclyn Samek; Kevin Manning; Marilyn S Albert; Karen Bandeen-Roche
Journal:  Neuropsychology       Date:  2009-09       Impact factor: 3.295

8.  The value of clock drawing in identifying executive cognitive dysfunction in people with a normal Mini-Mental State Examination score.

Authors:  Angela Juby; Shirley Tench; Victoria Baker
Journal:  CMAJ       Date:  2002-10-15       Impact factor: 8.262

9.  Dysexecutive and amnesic AD subtypes defined by single indicator and modern psychometric approaches: relationships with SNPs in ADNI.

Authors:  Shubhabrata Mukherjee; Emily Trittschuh; Laura E Gibbons; R Scott Mackin; Andrew Saykin; Paul K Crane
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

10.  Mild cognitive impairment: searching for the prodrome of Alzheimer's disease.

Authors:  Paul B Rosenberg; Constantine Lyketsos
Journal:  World Psychiatry       Date:  2008       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.